With the implementation of GST 2.0, consumers can anticipate lower prices on various products as businesses pass on reduced tax rates. Food...

India should eliminate tax on drugs for cancer treatment and chronic diseases, urged Biocon's chairperson Kiran Mazumdar-Shaw, ahead of the...

AIMIM leader Asaduddin Owaisi praised Palestine after taking his oath in the 18th Lok Sabha, sparking an uproar and leading to calls for hi...

West Bengal Chief Minister Mamata Banerjee on Monday said that the BJP might conduct the Lok Sabha polls in December itself, claiming that ...

Exide Industries plans to regain its pre-pandemic EBITDA margin of 13-14% within the next one to two years after its current margin reached...

Over the past month, Alexei Navalny, a prominent critic of the Kremlin, has been facing a trial in secret at the IK-6 penal colony in Melek...

Xiaomi turned around its India business in FY22 with the company's turnover growing more than 9% to Rs 39,099 crore, topping the pre-pandem...

The Company, which has been a forerunner in introducing cutting-edge technologies, demonstrated its futuristic vehicle range, powered by el...

On May 15, 2021, the ministry's investigation arm Directorate General of Trade Remedies (DGTR) initiated a probe into alleged dumping of "s...

"The competent authority has accepted the request of extending time for completing the on-going anti-dumping (original) investigation on im...

Biocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pha...

The firm, which has a small 70 MW manufacturing plant in Greater Noida at present, is confident about competing with Chinese imports.

Called ALZUMAb, it took 10 years in the making and "is recognition of innovation done by research and development wing of Biocon," said Kir...

RA Sengupta and Shiladitya Mashelkar have set up a Delhi-based co, Invictus Oncology, to take a modified Cisplatin to the market.

The company is all set to launch fifth biosimilar drug and seeks approvals for clinical trials and stem-cell treatment.

Mukesh Ambani-owned Reliance Life Sciences to launch biosimilar drug in Europe within a year since it has completed all required testing an...

The Indian Music Industry (IMI) says the total loss to music industry due to piracy is around 600-700 crores per year, out of which music p...